G. Wilkinson

47.2k total citations · 19 hit papers
403 papers, 35.3k citations indexed

About

G. Wilkinson is a scholar working on Organic Chemistry, Inorganic Chemistry and Oncology. According to data from OpenAlex, G. Wilkinson has authored 403 papers receiving a total of 35.3k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Organic Chemistry, 93 papers in Inorganic Chemistry and 92 papers in Oncology. Recurrent topics in G. Wilkinson's work include Organometallic Complex Synthesis and Catalysis (94 papers), Pharmacogenetics and Drug Metabolism (77 papers) and Drug Transport and Resistance Mechanisms (51 papers). G. Wilkinson is often cited by papers focused on Organometallic Complex Synthesis and Catalysis (94 papers), Pharmacogenetics and Drug Metabolism (77 papers) and Drug Transport and Resistance Mechanisms (51 papers). G. Wilkinson collaborates with scholars based in United States, United Kingdom and Japan. G. Wilkinson's co-authors include David G. Shand, Richard B. Kim, John A. Osborn, T. A. STEPHENSON, Robert A. Branch, John Birmingham, T. S. Piper, Kenneth E. Thummel, F. H. Jardine and J.F. Young and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of the American Chemical Society.

In The Last Decade

G. Wilkinson

399 papers receiving 32.9k citations

Hit Papers

A physiological approach to hepatic drug clearance 1954 2026 1978 2002 1975 1966 1998 2005 2005 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A physiological approach to hepatic drug clearance
    1975 1.5k citations G. Wilkinson et al. Clinical Pharmacology & Therapeutics profile →
  2. The preparation and properties of tris(triphenylphosphine)halogenorhodium(I) and some reactions thereof including catalytic homogeneous hydrogenation of olefins and acetylenes and their derivatives
    1966 1.1k citations G. Wilkinson et al. profile →
  3. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
    1998 910 citations Richard B. Kim, Martin F. Fromm et al. Journal of Clinical Investigation profile →
  4. Drug Metabolism and Variability among Patients in Drug Response
    2005 826 citations G. Wilkinson New England Journal of Medicine profile →
  5. Lorazepam Is an Independent Risk Factor for Transitioning to Delirium in Intensive Care Unit Patients
    2005 793 citations Ayumi Shintani, G. Wilkinson et al. profile →
  6. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.
    1994 793 citations G. Wilkinson, Joyce Blaisdell et al. profile →
  7. IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A
    1998 703 citations G. Wilkinson et al. profile →
  8. New complexes of ruthenium (II) and (III) with triphenylphosphine, triphenylarsine, trichlorostannate, pyridine and other ligands
    1966 677 citations G. Wilkinson et al. profile →
  9. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.
    1994 649 citations G. Wilkinson, Joyce Blaisdell et al. profile →
  10. Dichlorotetrakis(dimethyl sulphoxide)ruthenium(II) and its use as a source material for some new ruthenium(II) complexes
    1973 629 citations G. Wilkinson et al. profile →
  11. Alkyl and aryl derivatives of π-cyclopentadienyl compounds of chromium, molybdenum, tungsten, and iron
    1956 611 citations G. Wilkinson et al. profile →
  12. The effects of age and liver disease on the disposition and elimination of diazepam in adult man.
    1975 521 citations G. Wilkinson et al. Journal of Clinical Investigation profile →
  13. Hydroformylation of alkenes by use of rhodium complex catalysts
    1968 520 citations G. Wilkinson et al. profile →
  14. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*
    1996 509 citations G. Wilkinson et al. Clinical Pharmacology & Therapeutics profile →
  15. OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine
    1999 500 citations Brenda F. Leake, Martin F. Fromm et al. profile →
  16. 667. Carboxylates of palladium, platinum, and rhodium, and their adducts
    1965 389 citations G. Wilkinson et al. profile →
  17. Bis-cyclopentadienyl Compounds of Ti, Zr, V, Nb and Ta
    1954 378 citations G. Wilkinson et al. Journal of the American Chemical Society profile →
  18. Cyclopentadienyl-carbon monoxide and related compounds of some transitional metals
    1955 311 citations G. Wilkinson et al. profile →
  19. Homogeneous hydroformylation of alkenes with hydridocarbonyltris-(triphenylphosphine)rhodium(I) as catalyst.
    1970 259 citations G. Wilkinson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Wilkinson United States 93 11.0k 9.5k 9.0k 7.0k 4.0k 403 35.3k
T.L. Poulos United States 75 2.2k 0.2× 2.6k 0.3× 6.2k 0.7× 5.4k 0.8× 694 0.2× 338 25.1k
F. Peter Guengerich United States 127 4.5k 0.4× 16.8k 1.8× 37.6k 4.2× 3.0k 0.4× 3.2k 0.8× 941 68.3k
Matthias Schwab Germany 95 1.0k 0.1× 9.2k 1.0× 8.7k 1.0× 771 0.1× 6.4k 1.6× 792 45.9k
Corwin Hansch United States 66 13.2k 1.2× 2.2k 0.2× 1.2k 0.1× 2.2k 0.3× 217 0.1× 335 33.2k
Bernard Meunier France 74 6.8k 0.6× 4.5k 0.5× 1.0k 0.1× 6.2k 0.9× 166 0.0× 475 24.0k
Jos H. Beijnen Netherlands 111 3.3k 0.3× 27.4k 2.9× 6.0k 0.7× 399 0.1× 7.5k 1.9× 1.5k 57.9k
Salvador Moncada United Kingdom 161 3.0k 0.3× 2.7k 0.3× 2.7k 0.3× 572 0.1× 3.1k 0.8× 621 123.8k
Ronald P. Mason United States 97 5.0k 0.5× 1.5k 0.2× 1.6k 0.2× 1.1k 0.2× 577 0.1× 659 33.3k
Marián Valko Slovakia 41 3.5k 0.3× 2.4k 0.3× 1.4k 0.2× 1.3k 0.2× 683 0.2× 166 34.4k
Kaoru Kobayashi Japan 79 6.5k 0.6× 3.4k 0.4× 2.3k 0.3× 565 0.1× 602 0.1× 550 24.6k

Countries citing papers authored by G. Wilkinson

Since Specialization
Citations

This map shows the geographic impact of G. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Wilkinson more than expected).

Fields of papers citing papers by G. Wilkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Wilkinson. The network helps show where G. Wilkinson may publish in the future.

Co-authorship network of co-authors of G. Wilkinson

This figure shows the co-authorship network connecting the top 25 collaborators of G. Wilkinson. A scholar is included among the top collaborators of G. Wilkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Wilkinson. G. Wilkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiehao, G. Wilkinson, Di Wang, et al.. (2025). Spin Glass Behavior and Giant Magnetoresistance via Aliovalent Fe/Ni Alloying in Amorphous Tetrathiafulvalene-Tetrathiolate Coordination Polymers. Journal of the American Chemical Society. 147(43). 39590–39598.
2.
Haas, David W., Tebeb Gebretsadik, Gail Mayo, et al.. (2009). Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans. The Journal of Infectious Diseases. 199(6). 872–880. 88 indexed citations
3.
Ribaudo, Heather J., David W. Haas, C. Tierney, et al.. (2006). Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study. Clinical Infectious Diseases. 42(3). 401–407. 170 indexed citations
4.
Motsinger‐Reif, Alison A., Marylyn D. Ritchie, Robert W. Shafer, et al.. (2006). Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study. Pharmacogenetics and Genomics. 16(11). 837–845. 50 indexed citations
5.
Wilkinson, G.. (2005). Drug Metabolism and Variability among Patients in Drug Response. New England Journal of Medicine. 352(21). 2211–2221. 826 indexed citations breakdown →
6.
Wood, Alastair J.J., et al.. (2004). Genetic Variability in CYP3A5 and its Possible Consequences. Pharmacogenomics. 5(3). 243–272. 230 indexed citations
7.
Haas, David W., Hulin Wu, Haihong Li, et al.. (2003). MDR1 Gene Polymorphisms and Phase 1 Viral Decay During HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(3). 295–298. 49 indexed citations
8.
Sofowora, G., Edna F. Choo, Gail Mayo, Yu Shyr, & G. Wilkinson. (2001). In vivo inhibition of human CYP1A2 activity by oltipraz. Cancer Chemotherapy and Pharmacology. 47(6). 505–510. 27 indexed citations
9.
Ibeanu, Gordon C., Joyce Blaisdell, Ronald J. Ferguson, et al.. (1999). A Novel Transversion in the Intron 5 Donor Splice Junction of CYP2C19 and a Sequence Polymorphism in Exon 3 Contribute to the Poor Metabolizer Phenotype for the Anticonvulsant Drug S-Mephenytoin. Journal of Pharmacology and Experimental Therapeutics. 290(2). 635–640. 87 indexed citations
10.
Fromm, Martin F., Brenda F. Leake, Dan M. Roden, G. Wilkinson, & Richard B. Kim. (1999). Human MRP3 transporter: identification of the 5′-flanking region, genomic organization and alternative splice variants1The GenBank accession numbers of MRP3 and its splice variants MRP3A and MRP3B described in this paper are AF085690, AF085691 and AF085692, respectively.1. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1415(2). 369–374. 30 indexed citations
11.
Kim, Richard B., Martin F. Fromm, Brenda F. Leake, et al.. (1998). The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.. Journal of Clinical Investigation. 101(2). 289–294. 910 indexed citations breakdown →
12.
Darbar, Dawood, Simonetta Dell’Orto, Klaus Mörike, G. Wilkinson, & Dan M. Roden. (1997). Dietary salt increases first-pass elimination of oral quinidine*. Clinical Pharmacology & Therapeutics. 61(3). 292–300. 37 indexed citations
13.
Takahashi, Hitoshi, et al.. (1997). Characterization of the Hepatic Canalicular Membrane Transport of a Model Oligopeptide: Ditekiren. Journal of Pharmacology and Experimental Therapeutics. 281(1). 297–303. 15 indexed citations
14.
Kim, Richard B., et al.. (1997). High affinity uptake by isolated rat hepatocytes of a linear pseudo-hexapeptide, ditekiren. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1328(1). 41–47. 3 indexed citations
15.
Porter, James I., et al.. (1994). Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population. Clinical Pharmacology & Therapeutics. 55(5). 492–500. 71 indexed citations
16.
Chern, Herng‐Der, Raj Persad, G. Sibley, et al.. (1994). Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity. Carcinogenesis. 15(9). 1955–1961. 18 indexed citations
17.
Adedoyin, Adedayo, et al.. (1990). Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clinical Pharmacology & Therapeutics. 48(1). 10–17. 68 indexed citations
18.
Biollaz, Jérôme, et al.. (1989). Influence of debrisoquin phenotype on the inducibility of propranolol metabolism. Clinical Pharmacology & Therapeutics. 45(4). 439–443. 14 indexed citations
19.
Wilson, John T. & G. Wilkinson. (1973). Chronic and severe phenobarbital intoxication in a child treated with primidone and diphenylhydantoin. The Journal of Pediatrics. 83(3). 484–489. 10 indexed citations
20.
Price, W. C., W.F. Sherman, & G. Wilkinson. (1958). Infra-red studies of water adsorbed on alkali halides. Proceedings of the Royal Society of London A Mathematical and Physical Sciences. 247(1251). 467–468. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T.L. Poulos Breakdown of academic impact, for papers by F. Peter Guengerich Breakdown of academic impact, for papers by Matthias Schwab Breakdown of academic impact, for papers by Corwin Hansch Breakdown of academic impact, for papers by Bernard Meunier Breakdown of academic impact, for papers by Jos H. Beijnen Breakdown of academic impact, for papers by Salvador Moncada Breakdown of academic impact, for papers by Ronald P. Mason Breakdown of academic impact, for papers by Marián Valko Breakdown of academic impact, for papers by Kaoru Kobayashi
Rankless by CCL
2026